SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457612-22-000009
Filing Date
2022-03-07
Accepted
2022-03-07 18:14:28
Documents
1
Period of Report
2022-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164669484940152.html 4  
1 FORM 4 wf-form4_164669484940152.xml 4 3896
  Complete submission text file 0001457612-22-000009.txt   5396
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADAPTIMMUNE THERAPEUTICS PLC 60 JUBILEE AVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address
Lunger John (Reporting) CIK: 0001784487 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 22719663